Skip to main content
Premium Trial:

Request an Annual Quote

Amersham Licenses Tagging and Imaging Systems to Lilly

NEW YORK, Nov. 7 (GenomeWeb News) - Amersham announced today that Eli Lilly has licensed the rights to Amersham's Aequorea Victoria Green Fluorescent Protein and has secured rights to operate under Biolmage's Redistribution patent portfolio for monitoring intracellular signaling pathways.

 

Lilly will use the licensed technologies, along with a recently purchased IN Cell Analyzer 3000 high-throughput imaging system from Amersham, to look at drug targets in a biological context, the companies said.

 

Financial details of the agreement were not disclosed.

 

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.